FilingReader Intelligence
Kyowa Kirin to liquidate Orchard Therapeutics subsidiary
July 14, 2025 at 07:03 AM UTC•By FilingReader AI
Kyowa Kirin will liquidate Orchard Therapeutics Limited, a subsidiary acquired in January 2024, transferring operations to another unit.
The biotech company reported a net loss of $65.9m in 2024 with total assets of $372.5m. Kyowa Kirin said the impact on consolidated results would be minor.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
TSE:4151•Tokyo Stock Exchange
News Alerts
Get instant email alerts when Kyowa Kirin publishes news
Free account required • Unsubscribe anytime